GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pakistan Ltd (KAR:GLAXO) » Definitions » PB Ratio

GlaxoSmithKline Pakistan (KAR:GLAXO) PB Ratio : 5.26 (As of Mar. 26, 2025)


View and export this data going back to 1953. Start your Free Trial

What is GlaxoSmithKline Pakistan PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-26), GlaxoSmithKline Pakistan's share price is ₨417.15. GlaxoSmithKline Pakistan's Book Value per Share for the quarter that ended in Sep. 2024 was ₨79.29. Hence, GlaxoSmithKline Pakistan's PB Ratio of today is 5.26.

The historical rank and industry rank for GlaxoSmithKline Pakistan's PB Ratio or its related term are showing as below:

KAR:GLAXO' s PB Ratio Range Over the Past 10 Years
Min: 1.07   Med: 3.3   Max: 6.22
Current: 5.26

During the past 13 years, GlaxoSmithKline Pakistan's highest PB Ratio was 6.22. The lowest was 1.07. And the median was 3.30.

KAR:GLAXO's PB Ratio is ranked worse than
84.36% of 940 companies
in the Drug Manufacturers industry
Industry Median: 1.895 vs KAR:GLAXO: 5.26

During the past 12 months, GlaxoSmithKline Pakistan's average Book Value Per Share Growth Rate was 22.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 7.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 8.00% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 7.20% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of GlaxoSmithKline Pakistan was 10.80% per year. The lowest was -4.10% per year. And the median was 5.70% per year.

Back to Basics: PB Ratio


GlaxoSmithKline Pakistan PB Ratio Historical Data

The historical data trend for GlaxoSmithKline Pakistan's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Pakistan PB Ratio Chart

GlaxoSmithKline Pakistan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.17 3.50 2.07 1.33 1.22

GlaxoSmithKline Pakistan Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.11 1.22 1.21 1.96 2.43

Competitive Comparison of GlaxoSmithKline Pakistan's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, GlaxoSmithKline Pakistan's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Pakistan's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pakistan's PB Ratio distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Pakistan's PB Ratio falls into.



GlaxoSmithKline Pakistan PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

GlaxoSmithKline Pakistan's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=417.15/79.292
=5.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


GlaxoSmithKline Pakistan  (KAR:GLAXO) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


GlaxoSmithKline Pakistan PB Ratio Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pakistan's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Pakistan Business Description

Traded in Other Exchanges
N/A
Address
35, Dockyard Road, West Wharf, Karachi, PAK, 74000
GlaxoSmithKline Pakistan Ltd is engaged in research, development, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. It is involved in Anti-infective, Respiratory, Vaccines, Dermatological, Gastrointestinal, Analgesics, Urology, Central Nervous System, Allergy, Cardiovascular and Vitamins therapy areas. The operating business divisions are Pharmaceuticals and Consumer Healthcare. The pharmaceutical brands of the company include Augmentin, Seretide, Amoxil, Velosef, Zantac and Calpol and prominent vaccines include Synflorix, Infanrix Hexa, Rotarix, Engerix-B, Havrix, and Cervarix. The company derives maximum revenue from Pharmaceuticals segment.

GlaxoSmithKline Pakistan Headlines

No Headlines